From research tool to routine test: CD38 monitoring in HIV patients

Cytometry Part B - Clinical Cytometry

Volumn 76, Issue 6, 2009, Pages 375-384

  Coetzee, Lindi M ^a   Tay, Szun Szun ^b   Lawrie, Denise ^a   Janossy, George ^a   Glencross, Deborah K ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CD38; CD4; CD8; HIV infection; Panleucogating; Quality control; Standardization

Indexed keywords

CD3 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY CONTROL;

ANTIGENS, CD38; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTE SUBSETS;

EID: 75149117396     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20478     Document Type: Article

References (43)

1. Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, Vaisitti T, Aydin S. Evolution and function of the ADP ribosyl cyclase/ CD38 gene family in physiology and pathology. Physiol Rev 2008;88:841-886.
2. Levacher M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ, Bach BA. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol 1992;90:376-382.
3. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: Results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993;6:904-912.
4. Liu Z, Cumberland WG, Hultin LE, Kaplan AH, Detels R, Giorgi JV. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodefi-ciency. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18: 332-340.
5. Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA, Timms A, Winter M, Baptista L, Johnson MA, Lee CA, Phillips AN, Janossy G. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS 1996;10:827-834.
6. Tilling R, Kinloch S, Goh LE, Cooper D, Perrin L, Lampe F, Zaunders J, Hoen B, Tsoukas C, Andersson J, Janossy G; Quest Study Group. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS 2002;16:589-596.
7. Giorgi JV, Lyles RH, Matud JL, Yamashita TE, Mellors JW, Hultin LE, Jamieson BD, Margolick JB, Rinaldo CR Jr, Phair JP, Detels R; Multicenter AIDS Cohort Study. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 2002;29:346-355.
8. Benito JM, Lopez M, Lozano S, Ballesteros C, Martinez P, Gonzalez-Lahoz J, Soriano V. Differential upregulation of CD38 on different Tcell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2005;38:373-381.
9. Glencross DK, Janossy G, Coetzee LM, Lawrie D, Scott LE, Sanne I, McIntyre JA, Stevens W. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: Findings from the first year of the CIPRA-SA cohort. Cytometry B Clin Cytom 2008; 74B(Suppl 1):S131-S140.
10. Tuaillon E, Al Tabaa Y, Baillat V, Segondy M, Picot M, Reynes J, Vendrell J. Clos asociation of CD8+/CD38bright with HIV-1 replication and complex relationship with CD4+ T-cell count. Cytometry B Clin Cytom 2009;76B: in press [doi: 10.1002/cyto.b.20467].
11. Hultin LE, Matud JL, Giorgi JV. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator. Cytometry 1998;33:123-132.
12. Bikoue A, George F, Poncelet P, Mutin M, Janossy G, Sampol J. Quantitative analysis of leukocyte membrane antigen expression: Normal adult values. Cytometry 1996;26:137-147.
13. Poncelet P, Poinas G, Corbeau P, Devaux C, Tubiana N, Muloko N, Tamalet C, Chermann JC, Kourilsky F, Sampol J. Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease. Res Immunol 1991;142:291-298.
14. Iyer SB, Hultin LE, Zawadzki JA, Davis KA, Giorgi JV. Quantitation of CD38 expression using QuantiBRITE beads. Cytometry 1998;33:206-212.
15. Gratama JW, D'Hautcourt JL, Mandy F, Rothe G, Barnett D, Janossy G, Papa S, Schmitz G, Lenkei R. Flow cytometric quantitation of immunofluorescence intensity: Problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry 1998;33:166-178.
16. Bikoue A, Janossy G, Barnett D. Stabilised cellular immuno-fluorescence assay: CD45 expression as a calibration standard for human leukocytes. J Immunol Methods 2002;266(1/2):19-32.
17. Wang L, Abbasi F, Gaigalas AK, Hoffman RA, Flagler D, Marti GE. Discrepancy in measuring CD4 expression on T-lymphocytes using fluorescein conjugates in comparison with unimolar CD4-phycoerythrin conjugates. Cytometry B Clin Cytom 2007;72B: 442-449.
18. Connelly MC, Knight M, Giorgi JV, Kagan J, Landay AL, Parker JW, Page E, Spino C, Wilkening C, Mercolino TJ. Standardization of absolute CD4+ lymphocyte counts across laboratories: An evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors. Cytometry 1995;22:200-210.
19. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ Tcell enumeration. Cytometry 2002;50:69-77.
20. Glencross DK, Janossy G, Coetzee LM, Lawrie D, Aggett HM, Scott LE, Sanne I, McIntyre JA, Stevens W. Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: In support of the South African national comprehensive care, treatment and management programme for HIV and AIDS. Cytometry B Clin Cytom 2008;74B(Suppl 1):S40-S51.
21. Reimann KA, O'Gorman MR, Spritzler J, Wilkening CL, Sabath DE, Helm K, Campbell DE. Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: Evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group. Clin Diagn Lab Immunol 2000;7:344-351.
22. Schnizlein-Bick CT, Spritzler J, Wilkening CL, Nicholson JK, O'Gorman MR. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency viruspositive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group. Clin Diagn Lab Immunol 2000;7:336-343.
23. Janossy G, Jani IV, Bradley NJ, Bikoue A, Pitfield T, Glencross DK. Affordable CD4(+)-T-cell counting by flow cytometry: CD45 gating for volumetric analysis. Clin Diagn Lab Immunol 2002;9:1085-1094.
24. Scott LE, Glencross DK. Monitoring reproducibility of single analysis, single platform CD4 cell counts in a high volume, low resource laboratory setting using sequential bead count rates. Cytometry B Clin Cytom 2005;67B:31-32.
25. Scott LE, Galpin JS, Glencross DK. Multiple method comparison: Statistical model using percentage similarity. Cytometry B Clin Cytom 2003;54:46-53.
26. Coskun A. Modified Levey-Jennings charts for calculated laboratory tests. Clin Chem Lab Med 2006;44:387-390.
27. Giorgi JV. Characterization of T lymphocyte subset alterations by flow cytometry in HIV disease. Ann NY Acad Sci 1993;677:126-137.
28. Schmitz JL, Czerniewski MA, Edinger M, Plaeger S, Gelman R, Wilkening CL, Zawadzki JA, Wormsley SB. Multisite comparison of methods for the quantitation of the surface expression of CD38 on CD8(+) T lymphocytes. The ACTG Advanced Flow Cytometry Focus Group. Cytometry 2000;42:174-179.
29. Almeida M, Cordero M, Almeida J, Orfao A. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: A one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients. Cytometry B Clin Cytom 2007;72B:22-33.
30. Storie I, Sawle A, Whitby L, Goodfellow K, Granger V, Reilly JT, Barnett D. Flow rate calibration II: A clinical evaluation study using PanLeucoGating as a single-platform protocol. Cytometry B Clin Cytom 2003;55B:8-13.
31. Caldwell CW, Maggi J, Henry LB, Taylor HM. Fluorescence intensity as a quality control parameter in clinical flow cytometry. Am J Clin Pathol 1987;88:447-456.
32. Arroz MJ, Freire M, Pinto L, Aldir I, Campos M, Rodrigues G, Mansinho K, Matos R, Ventura F, Caetano JM. CD38 as a surrogate marker of viral load in HIV infection. 5th Euroconference on Clinical Cell Analysis, European Working Group on Clinical Cell Analysis (EWGCCA) Athens (Greece); 2005.
33. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006;443:350-354.
34. Elrefaei M, Baker CA, Jones NG, Bangsberg DR, Cao H. Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells. J Immunol 2008;180: 7757-7763.
35. Holm M, Pettersen FO, Kvale D. PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples. Curr HIV Res 2008;6:49-58.
36. Sauce D, Almeida JR, Larsen M, Haro L, Autran B, Freeman GJ, Appay V. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS 2007;21:2005-2013.
37. Zhang JY, Zhang Z, Wang X, Fu JL, Yao J, Jiao Y, Chen L, Zhang H, Wei J, Jin L, Shi M, Gao GF, Wu H, Wang FS. PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007;109:4671-4678.
38. Faller E, Kakal J, Kumar R, Macpherson P. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells. Int Immunol 2009;21:203-216.
39. Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection. J Leukoc Biol 2008;83:254-262.
40. Read SW, Higgins J, Metcalf JA, Stevens RA, Rupert A, Nason MC, Lane HC, Sereti I. Decreased CD127 expression on T cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy. J Acquir Immune Defic Syndr 2006; 42:537-544.
41. Wu JQ, Dyer WB, Chrisp J, Belov L, Wang B, Saksena NK. Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy. Retrovirology 2008;5:24.
42. Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM, Gyenes G, Vali B, Hyrcza MD, Yue FY, Kovacs C, Sassi A, Loutfy M, Halpenny R, Persad D, Spotts G, Hecht FM, Chun TW, McCune JM, Kaul R, Rini JM, Nixon DF, Ostrowski MA. Tim-3 expression defines a novel
43. population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008;205:2763-2779.